Parkinson disease develops when nerve cells in a specific brain region stop producing enough dopamine
Parkinson disease happens because of a loss of cells in the substantia nigra, a small area deep in the brain that makes dopamine—a chemical messenger that coordinates movement. When these cells die or stop working, dopamine levels drop, and the brain can no longer send smooth signals to your muscles. The result is the tremor, stiffness, and slowness of movement that define the disease. Why these cells die is not fully understood, but research points to a combination of aging, genetics, and environmental factors working together over years or decades.
The cell death in Parkinson disease involves a protein called alpha-synuclein. In people who develop Parkinson disease, this protein misfolds and clumps inside nerve cells, damaging them from within. Scientists are still working to understand exactly why this happens in some people and not others, and whether stopping these clumps could slow or prevent the disease. This is an active area of research, and no treatment yet reverses the cell loss—current medications work around the problem by boosting dopamine or making the dopamine that remains work more effectively.
Key Takeaways
- Parkinson disease occurs when dopamine-producing nerve cells in the brain die or malfunction, most commonly in people over 60.
- Genetics play a role—having a parent or sibling with Parkinson disease increases your risk—but most people with the disease have no family history.
- Environmental exposures like pesticides and head injuries may raise risk, but no single exposure causes the disease on its own.
- The disease develops slowly over years, often starting with subtle tremor, stiffness, or slowness before becoming noticeable.
Age is the strongest known risk factor
Parkinson disease is rare before age 50 and becomes more common as people age. The average age of diagnosis is around 60, though some people develop symptoms earlier. The reason age matters is not fully clear—it may be that dopamine-producing cells are simply more vulnerable to damage over a long lifetime, or that it takes decades for the toxic protein clumps to accumulate enough to cause symptoms. Aging also involves natural decline in the brain's ability to clear damaged proteins, which may allow alpha-synuclein to build up.
This age pattern means that Parkinson disease is not something you catch or acquire suddenly in middle age. The biological changes that lead to it likely begin years before any symptom appears. Some research suggests that people who will later develop Parkinson disease may have subtle changes in smell, sleep, or mood a decade or more before movement problems show up. This is why researchers are interested in finding ways to identify people at risk before symptoms start, though no screening test for this exists yet.
Genetics increase risk but do not may provide the disease
Having a parent, sibling, or child with Parkinson disease raises your own risk. If one parent has the disease, your lifetime risk is roughly 2 to 3 times higher than someone with no family history—still a minority of people, but a meaningful increase. Researchers have identified several genes that, when mutated, raise risk or directly cause early-onset Parkinson disease (before age 50). The most studied are LRRK2, SNCA, and GBA. However, most people with Parkinson disease do not carry mutations in these genes, and many people who do carry the mutations never develop the disease.
Genetics appears to work as one piece of a larger puzzle rather than a single cause. A person might inherit a gene that makes dopamine cells more vulnerable, but whether those cells actually die may depend on other factors—environmental exposures, head injuries, or simply chance. This is why identical twins, who share all their DNA, do not always both develop Parkinson disease. If you have a family history, your risk is higher, but it is not certain. Genetic testing can identify some mutations, but it cannot predict whether you will develop symptoms.
Environmental exposures may increase risk over time
Pesticide exposure is the environmental factor most consistently linked to Parkinson disease in research. People who work with pesticides—particularly farmers and agricultural workers—have higher rates of the disease than the general population. The mechanism is not completely understood, but some pesticides may damage dopamine-producing cells directly or trigger the accumulation of toxic proteins. Other occupational exposures under study include welding (manganese exposure) and certain solvents used in manufacturing.
Head injury, especially repeated head trauma, has also been associated with higher Parkinson disease risk in some studies. This connection is still being investigated—it is not clear whether a single head injury raises risk or whether repeated impacts over years matter more. Environmental factors alone do not cause Parkinson disease in most people; rather, they may act as one contributor in someone who is already genetically predisposed or aging. Living in a rural area, drinking well water, or having had certain infections have been studied as possible risk factors, but the evidence remains uncertain and does not apply uniformly across populations.
Symptoms develop gradually, often over years
Parkinson disease does not appear overnight. Most people notice the first symptoms gradually—a slight tremor in one hand, stiffness on one side of the body, or a slowness in movement that seems like normal aging at first. Early symptoms can be so mild that people dismiss them or attribute them to something else. A person might notice their handwriting is smaller, they move more slowly, or their face feels stiff. Some people report that their sense of smell changed years before any movement problem appeared.
The disease typically starts on one side of the body and spreads to the other over months or years. This gradual onset is one reason diagnosis can be delayed—there is no blood test or imaging scan that definitively shows Parkinson disease, so doctors rely on observing symptoms and how they respond to medication. By the time someone seeks medical attention, the underlying cell loss has usually been happening for years. This slow progression is why researchers are interested in identifying the disease earlier, before significant dopamine loss has occurred, though no way to do this reliably exists yet.
Other conditions can mimic Parkinson disease symptoms
Several other neurological conditions produce tremor, stiffness, or slowness that resembles Parkinson disease but has a different cause. Parkinsonism is the term for this group of similar-looking conditions. Some are caused by medications (particularly antipsychotics), some by repeated head trauma, some by toxin exposure, and some by other neurodegenerative diseases. Distinguishing true Parkinson disease from these look-alikes requires a neurologist's evaluation and sometimes specialized imaging or tests.
This distinction matters because the underlying cause changes what treatment options might help. A person whose symptoms are caused by a medication might improve by stopping or changing that drug. Someone with a different neurodegenerative disease might need a different approach. This is why diagnosis by a movement disorder specialist—a neurologist with extra training in Parkinson disease—is more reliable than diagnosis by a general practitioner. If you have been diagnosed with Parkinson disease, asking whether your doctor is certain about the diagnosis, or whether a specialist evaluation would be helpful, is a reasonable question.
What researchers still do not know
Despite decades of research, the fundamental question remains unanswered: why do dopamine-producing cells die in Parkinson disease? Scientists have identified pieces of the puzzle—alpha-synuclein clumping, mitochondrial dysfunction, inflammation in the brain—but how these pieces fit together, and which one matters most, is still unclear. This uncertainty is why no treatment yet stops or reverses the disease. Current medications manage symptoms by boosting dopamine or making existing dopamine work better, but they do not address the underlying cell death.
Research is ongoing into whether anti-inflammatory drugs, antioxidants, or other approaches might slow the disease if given early enough. Clinical trials are testing whether targeting alpha-synuclein, improving mitochondrial function, or modifying the immune response might help. However, no medication has yet been proven to slow Parkinson disease progression in humans. Understanding what causes the disease remains one of neurology's major unsolved problems, and solving it could eventually lead to prevention or early intervention before symptoms appear.
Frequently Asked Questions
Can you catch Parkinson disease from someone else?
No. Parkinson disease is not contagious and cannot be transmitted from one person to another. It develops because of changes in a person's own brain cells over time, not because of infection or exposure to a disease-causing agent from another person.
Does stress cause Parkinson disease?
Stress does not cause Parkinson disease, though stress may temporarily worsen symptoms in people who already have it. The disease develops because of dopamine cell loss in the brain, which is driven by aging, genetics, and possibly environmental factors—not by psychological stress.
If my parent has Parkinson disease, will I definitely get it?
No. Having a parent with Parkinson disease raises your risk, but most people with an affected parent never develop the disease. Risk depends on which genes you inherited, your age, and environmental factors—none of which are certain. Genetic testing can identify some high-risk mutations, but even then, not everyone with the mutation develops symptoms.
Can diet or supplements prevent Parkinson disease?
No diet or supplement has been proven to prevent Parkinson disease. Some research suggests that antioxidant-rich foods or regular exercise may be associated with lower risk, but this evidence is not strong enough to say prevention is possible. If you are concerned about risk, talking with your doctor about what the current evidence actually supports is more useful than trying unproven interventions.
Does head injury from sports cause Parkinson disease?
A single sports-related head injury is not known to cause Parkinson disease. Repeated head trauma over years, particularly in contact sports or boxing, has been studied as a possible risk factor, but the evidence is still uncertain. If you have had head injuries and are concerned, discussing your specific situation with a neurologist is more informative than general information.